CSIMarket
 
Standard Biotools Inc   (LAB)
Other Ticker:  
 
 
Price: $1.8900 $0.12 6.780%
Day's High: $1.9 Week Perf: 3.85 %
Day's Low: $ 1.77 30 Day Perf: -6.9 %
Volume (M): 1,428 52 Wk High: $ 3.04
Volume (M$): $ 2,699 52 Wk Avg: $2.23
Open: $1.77 52 Wk Low: $1.21



 Market Capitalization (Millions $) 150
 Shares Outstanding (Millions) 79
 Employees -
 Revenues (TTM) (Millions $) 105
 Net Income (TTM) (Millions $) -76
 Cash Flow (TTM) (Millions $) 19
 Capital Exp. (TTM) (Millions $) 4

Standard Biotools Inc
Standard Biotools Inc is a company specializing in the development and manufacturing of biotechnology tools and solutions. They provide a range of products and services that cater to the needs of the scientific community, including research laboratories, academic institutions, and pharmaceutical companies. The company is known for its high-quality and innovative biotech tools, such as DNA sequencing kits, PCR reagents, protein purification systems, and laboratory equipment. Standard Biotools Inc aims to facilitate scientific advancements and contribute to the progress of biotechnology by providing reliable and efficient tools for researchers and scientists.


   Company Address: 2 Tower Place South San Francisco 94080 CA
   Company Phone Number: 266-6000   Stock Exchange / Ticker: NASDAQ LAB


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
• View Complete Report
   



Clinical Study

Standard BioTools proteomics profiling reveals unique biomarkers and insights into nonalcoholic steatohepatitis (NASH)

Published Wed, Sep 18 2024 12:01 PM UTC

Comprehensive Proteomics Profiling Unveils Novel Biomarkers and Insights into Nonalcoholic Steatohepatitis (NASH)Interest in nonalcoholic steatohepatitis (NASH) has burgeoned in recent years as researchers deepen their understanding of its pathophysiology and resultant clinical sequelae. NASH, a severe form of nonalcoholic fatty liver disease (NAFLD), is characterized by li...

Contract

Standard BioTools Enhances SomaScan Platform with Cutting-Edge Carterra LSA-XT Systemb...

Published Tue, May 28 2024 8:01 PM UTC

Standard BioTools Purchases Carterra LSA-XT System to Enhance SomaScan PlatformStandard BioTools Inc., a biotechnology company, has recently acquired the LSA-XT system from Carterra, a leading provider of screening and characterization solutions for molecules. The purpose of this purchase is to further validate Standard BioTools' SomaScan platform by measuring the kinetic pr...

Management Announcement

Revitalizing Operational Excellence: Standard BioTools Spearheads Biotech Innovations for a Sustainable Future

Published Thu, Apr 25 2024 12:01 PM UTC

Standard BioTools Announces Operational Restructuring Plan to Drive Long-Term Profitable Growth
SOUTH SAN FRANCISCO, Calif., April 25, 2024 - Standard BioTools Inc. (Standard BioTools or the Company) (Nasdaq: LAB) today announced that it has initiated a restructuring plan to improve operational efficiency and reduce operating costs, while supporting the execution of the ...

Product Service News

Standard BioTools Unveils Revolutionary High-Throughput Imaging Technologies to Redefine Tissue Imaging and Propel Spatial Biology into New Frontiers

Published Mon, Apr 8 2024 12:00 PM UTC

Standard BioTools Introduces New High-Throughput Multiplexed Whole Slide Imaging Modalities Set to Redefine the Boundaries of Tissue ImagingAdvancements in spatial biology have always been a crucial aspect of medical research, allowing scientists to unravel the intricacies of cellular interactions within tissues. Standard BioTools, a leading provider of cutting-edge bioimagi...

Partnership

Augmenting Translational Medicine Research: Standard BioTools and Bristol Myers Squibb Forge a Path to Medical Breakthroughs

Published Wed, Apr 3 2024 8:01 PM UTC

In a groundbreaking announcement, Standard BioTools Inc. has revealed its strategic engagement with global biopharmaceutical company Bristol Myers Squibb, an alliance set to reshape the landscape of translational medicine research. This partnership will leverage the cutting-edge SomaScan Platform as a crucial tool for revolutionary clinical trials across multiple therapeutic...







Standard Biotools Inc's Segments





Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com